BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3583753)

  • 1. 99mTc bone scanning agents--V. Influence of experimental conditions on the labeling efficiency and gel chromatography of 99mTc(Sn)HMDP.
    Kroesbergen J; Wortelboer MR; Rijnsent A; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1987; 14(1):37-41. PubMed ID: 3583753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
    Kroesbergen J; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
    Kroesbergen J; Gelsema WJ; De Ligny CL
    Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 5. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel chromatographic analysis of the bone seeking radiopharmaceutical 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents.
    Huigen YM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1987; 38(8):615-8. PubMed ID: 2822619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
    Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
    Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
    Fukunaga M; Fujita T; Shigeno C; Morita R; Torizuka K
    Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research of 99mTcO4- and 99mTcO2- in injectable solutions of 99mTc-HMDP by inverse phase HPTLC].
    Jacquot Y; Zoubir B; Xicluna A; Bidet AC
    Ann Pharm Fr; 2006 Jan; 64(1):63-7. PubMed ID: 16449940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An experience with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) as a new bone scanning agent].
    Hayasaka K; Arakawa K; Sugie H; Amoh K
    Radioisotopes; 1984 Oct; 33(10):714-6. PubMed ID: 6522651
    [No Abstract]   [Full Text] [Related]  

  • 12. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of radiochemical purity of 99mTc(Sn)-methylene diphosphonate using gel chromatography].
    Vucina JL
    Med Pregl; 1995; 48(3-4):95-7. PubMed ID: 8657075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate.
    Hoch DJ; Pinkerton TC
    Int J Rad Appl Instrum A; 1986; 37(7):593-8. PubMed ID: 3021661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)].
    Ishii C; Mori Y; Hata Y; Katsuyama N; Fujioka M; Fukazawa W; Hashimoto H; Horiuchi T; Fujioka M; Kawakami K
    Radioisotopes; 1981 Jul; 30(7):401-3. PubMed ID: 7323328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
    Baum RP; Brandhorst I; Maul FD; Hör G
    Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intestinal accumulation of 99mTc-HMDP: an unusual finding in bone scintigraphy].
    Weismüller S; Baum RP; Zöller A; Hör G
    Nuklearmedizin; 1994 Apr; 33(2):142-4. PubMed ID: 8177758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
    Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
    Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Necessity of radiopharmaceutical control and vigilance].
    Ricordel I; Bussy E
    Ann Pharm Fr; 1995; 53(1):8-12. PubMed ID: 7741426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues.
    Tanabe S; Zodda JP; Deutsch E; Heineman WR
    Int J Appl Radiat Isot; 1983 Dec; 34(12):1577-84. PubMed ID: 6230322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.